Press Releases
Keyword Search
02.05.18
OpGen Regains Compliance With Nasdaq Listing Requirements
02.02.18
OpGen Announces Pricing of $12 Million Upsized Public Offering
02.01.18
OpGen Introduces New RUO Rapid Test for Infection Control and Surveillance Studies
01.17.18
OpGen Announces Execution of Reverse Stock Split
11.07.17
OpGen Reports 2017 Third Quarter Financial Results and Provides Business Update
10.26.17
OpGen Announces Date of Third Quarter 2017 Financial Results Conference Call
10.23.17
OpGen Awarded CDC Contract to Develop Clinical Support Tools for Antimicrobial Stewardship and Infection Control
10.13.17
OpGen to Present at Dawson James Securities 3rd Annual Small Cap Growth Conference
09.20.17
OpGen to Present at the Ladenburg Thalmann 2017 Healthcare Conference
09.08.17
OpGen Data on New Rapid Gene Test and Antibiotic Susceptibility Prediction Algorithms Presented at the 2017 ASM/ESCMID Conference